Unpacking market power: Why industry prices fell following a merger
The article “Estimating industry conduct using promotion data,” published in the RAND Journal of Economics by CRA’s Christian Michel, with Jose Manuel Paz y...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA experts prepare accounting, marketing and economic analyses relevant to Commercial Success, a secondary consideration in the determination of obviousness for patents. We provide clear and fact-supported testimony in all forums where the validity of patents is at issue, including in patent infringement litigation, PTAB IPRs, and in ITC Section 337 investigations. Our experts with deep experience in the pharmaceutical and life science sectors are particularly suited to addressing Commercial Success in ANDA/Hatch-Waxman litigation.
The article “Estimating industry conduct using promotion data,” published in the RAND Journal of Economics by CRA’s Christian Michel, with Jose Manuel Paz y...
Dr. Gregory K. Bell recently testified in three successful challenges to abbreviated new drug applications (ANDA) on behalf of pharmaceutical manufacturers...